New colorectal cancer drug shows promise in study

FDA approval will be sought this year for regorafenib, a medication that apparently slows tumor growth and extends life in advanced cases after other treatments fail. A medication for people with advanced colorectal cancer who have exhausted all other treatment options appears to slow tumor growth and extend life, according to new data.

Read the whole article on LA Times - Science

More from LA Times - Science